te Boekhorst Paul Francis Olivier 4

What Happened

Paul Francis Olivier te Boekhorst, President, CEO and a director of Immucell Corp (ICCC), reported a purchase of 8,000 common shares at $9.49 per share on June 18, 2026. The total cost of the transaction was $75,960. This was a direct purchase (transaction code P), which is generally viewed as an insider buying shares rather than selling.

Key Details

• Transaction date: 2026-06-18
• Price per share: $9.49; Shares purchased: 8,000; Total value: $75,960
• Transaction type: P = Purchase (reported as "open market or private purchase")
• Filing date: 2026-06-22 — filed within the required two business days, so not reported late
• Shares owned after transaction: Not specified in the provided summary; check the Form 4 for beneficial ownership totals and footnotes
• No 10b5-1 plan, tax withholding, or other special arrangements were disclosed in the information provided

Context

This was a straight share purchase (not an option exercise or award). Insider purchases can be interpreted by some investors as a sign of confidence in the company, but a single transaction should be considered alongside other insider activity and company fundamentals. For full details and exact post-transaction holdings, review the official Form 4 filing.